WednesdayMar 31, 2021 2:15 pm

Experts Say Vaccines Will Not Be Enough to End COVID-19 Pandemic

As the coronavirus vaccines become more accessible in the United States, two infectious disease experts from Georgetown University Medical Center assert that protecting oneself against the presymptomatic and asymptomatic spread of the SARS-CoV-2 virus, which causes the coronavirus, is the key to ending the pandemic. Both from the Georgetown University Center for Global Health Science and Security, Saskia V. Popescu and Angela L. Rasmussen published their research on the transmission of SARS-CoV-2 without symptoms in the “Science” journal on March 19. The researchers both claim that the symptomless transmission of the virus silently increases the spread of the virus and…

Continue Reading

TuesdayMar 30, 2021 1:30 pm

Research Finds That Covid-19 Infection Increases Chance of Stroke Among Patients

Research conducted recently has discovered that individuals who are hospitalized with coronavirus infections have an increased risk of stroke in comparison with individuals who have similar infectious illnesses such as sepsis and influenza from previous studies. The study found that patients who suffered from ischemic stroke were more likely to suffer from atrial fibrillations, type 2 diabetes, and high blood pressure, as well as come from the Black race, be male and be older. This was in comparison with other coronavirus patients. These findings were presented at this year’s American Stroke Association conference. For their evaluation, the researchers analyzed data…

Continue Reading

TuesdayMar 30, 2021 10:47 am

Healthy Extracts Inc. (HYEX) Leverages the Plant-Based Industry Boon For Continued Revenue Growth

Healthy Extracts Inc. recently declared its 2020 Q4 results showing an exponential revenue increase of 71% from last year The company’s proprietary Fuel4Thought(TM) Brain Booster product is undergoing clinical testing, and is slated for release in Q2 Healthy Extracts, Inc.(TM) officially changed its name from Grey Cloak Tech Inc. on March 1, 2020 Healthy Extracts (OTCQB: HYEX), is a leading researcher and manufacturer of plant-based formulations whose objective is to offer a better lifestyle through superior heart and brain health technology. The company is focused on strengthening and expanding its market reach through its science-based wholly-owned subsidiaries BergaMet North America (BergaMet…

Continue Reading

MondayMar 29, 2021 2:28 pm

Study Finds Cancer Survivors Have Higher Risk of Developing Heart Disease

A study conducted recently discovered that nearly 35% of Americans who have a history with cancer have a higher chance of contracting cardiovascular ailments in the next 10 years, as compared to roughly 23% of Americans who do not have cancer. Researchers from The Ohio State University discovered that the average approximated 10-year risk for an individual who survived cancer was nearly 8%, in comparison with individuals who did not have a cancer history, which was found to be 5%. This was based off of a risk calculator that approximates an individual's 10-year risk of developing stroke or heart disease.…

Continue Reading

MondayMar 29, 2021 12:29 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

GBM is diagnosed in more than 13,000 people each year in the US, with only a 12–18-month life expectancy Potentially pivotal Phase 2 trial of Berubicin is scheduled to commence around the end of Q1 2021 The company is continuing its pre-clinical work on WP1244 during 2021 and 2022 CNS Pharmaceuticals participated in two virtual conferences during March, spreading awareness about Berubicin and the GBM indicator CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system, recently announced multiple value-driving milestones for its lead drug candidate…

Continue Reading

MondayMar 29, 2021 11:29 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systems Helomics model evaluates multiple measurements in powerful multi-omics approach to cancer research Knowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to  Mark Collins, PhD and chief technical officer at the company, which is a subsidiary of Predictive Oncology (NASDAQ: POAI) (https://ibn.fm/ms1hL). Collins was a guest speaker on a DojoLIVE! podcast titled “Can We Cure Cancer with Artificial Intelligence?” where…

Continue Reading

FridayMar 26, 2021 1:00 pm

High Bladder Cancer Treatment Cost Finds Help with Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Technology

Bladder cancer is the 6th most prevalent cancer in the United States and a problem worldwide Bladder cancer is more common in men than women at a 4:1 ratio Bladder cancer treatment has the highest cost per patient over the course of a lifetime because of its greater than 50% recurrence rate Surgeons, including urologists at the University of Washington, have adopted a solution that uses blue light and a contrast agent to better visualize bladder tumors and has been shown to be more successful and reduce costs Imagin Medical has taken this solution one step further by developing the…

Continue Reading

FridayMar 26, 2021 1:00 pm

Researchers Have Found New Way to Hinder Excessive Inflammation

Researchers from the Royal College of Surgeons in Ireland have found another way to halt excessive inflammation. The method works by regulating a particular type of white blood cells that are crucial for the immune system in the human body. The researchers’ findings could potentially protect an individual’s body from the unhampered damage that is brought about by inflammatory ailments. The study, conducted by researchers at the University of Medicine and Health Sciences, Royal College of Surgeons in Ireland (“RCSI”), was reported in “Nature Communications” journal. The researchers explained that when the immune cells in an individual’s body known as…

Continue Reading

ThursdayMar 25, 2021 3:30 pm

Vanderbilt University Acquires Funds to Study Factors That Affect Coronavirus Severity

Vanderbilt University Medical Center (“VUMC”) was recently awarded a $3.7 million, two-year contract by the United States Centers for Disease Control (“CDC”), to discover the bacterial and genetic factors that may grow the risk for critical illness and death from the coronavirus. The investigation conducted by the center will find out how the severity of the coronavirus may be influenced by respiratory microbiome, which is the bacteria that is found in the airways of a patient, as well as the genetic makeup of a patient. Researchers from VUMC stated in a report, which was published in February, that the virus…

Continue Reading

WednesdayMar 24, 2021 12:15 pm

Study Finds Head Injuries Could Make Cognitive Decline Worse as Individuals Age

A study led by researchers from University College London has found that individuals who suffered head injuries when they were aged 50-something or below attained below-average scores on cognitive tests administered when they were age 70. The study’s findings, which were reported in the “Annals of Clinical and Translational Neurology,” found that while head injuries were not found to contribute to Alzheimer’s disease brain damage characteristics, they did make individuals more susceptible to symptoms of dementia. Dr. Sarah-Naomi James, the lead author of the study, explained that the researchers found irrefutable proof that head injuries in mid or early life…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050